OM
NRIX icon

Opaleye Management’s Nurix Therapeutics NRIX Stock Holding History

Opaleye Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-115,000
Closed -$1.37M – 45
2025
Q1 		$1.37M Sell
115,000
-263,500
-70% -$4.41M 0.3% 39
2024
Q4 		$7.13M Sell
378,500
-41,500
-10% -$951K 1.25% 18
2024
Q3 		$9.44M Buy
420,000
+1,072
+0.3% +$24.3K 1.57% 15
2024
Q2 		$8.74M Buy
418,928
+151,718
+57% +$2.36M 2% 14
2024
Q1 		$3.93M Buy
+267,210
New +$2.87M 0.86% 31

Other funds holding NRIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return